CLINICAL_TRIALS
ClinicalTrials.gov record update
Comparison of the Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema Using OCTA
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04991350
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:18.736539+00:00
- Published At
- 2023-02-16T00:00:00+00:00
- Record Updated At
- 2023-02-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diabetic Macular Edema", "Macular Ischemia", "Diabetic Retinopathy", "Vascular Endothelial Growth Factor Overexpression"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-02-16"- protocolSection.identificationModule.nctId
"NCT04991350"- protocolSection.identificationModule.officialTitle
"Comparison of the Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema Using OCTA"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.